These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4774246)

  • 1. Metabolism of 1,3-dicyclohexyl-5,5-diallylbarbituric acid in rabbits.
    Chyczewski T
    Pol J Pharmacol Pharm; 1973; 25(4):379-84. PubMed ID: 4774246
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of epoxides of allyl-substituted barbiturates in rat urine.
    Harvey DJ; Glazener L; Stratton C; Johnson DB; Hill RM; Horning EC; Horning MG
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):247-60. PubMed ID: 5074524
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. IV. Pharmacokinetics of BCP in man following oral administration.
    Yashiki T; Matsuzawa T; Yamada M; Kondo T; Uda Y
    Chem Pharm Bull (Tokyo); 1971 May; 19(5):869-80. PubMed ID: 5557927
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of nealbarbitone.
    Gilbert JN; Millard BJ; Powell JW; Whalley WB; Wilkins BJ
    J Pharm Pharmacol; 1974 Feb; 26(2):119-22. PubMed ID: 4150827
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. 3. Species differences in metabolism.
    Tanayama S
    Xenobiotica; 1973 Oct; 3(10):671-80. PubMed ID: 4774633
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. V. Pharmacokinetics of BCP in man man and in rabbit following intravenous administration of BCPNa.
    Yashiki T; Matsuzawa T; Yamada M; Kondo T; Mima H
    Chem Pharm Bull (Tokyo); 1971 May; 19(5):881-91. PubMed ID: 5557928
    [No Abstract]   [Full Text] [Related]  

  • 7. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
    Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole.
    Borchert P; Wislocki PG; Miller JA; Miller EC
    Cancer Res; 1973 Mar; 33(3):575-89. PubMed ID: 4689905
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of a 5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-metabolite of phenobarbital and mephobarbital in rat, guinea pig and human.
    Harvey DJ; Glazener L; Stratton C; Nowlin J; Hill RM; Horning MG
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):557-65. PubMed ID: 5034514
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value and indications of various intravenous induction agents].
    Parada JF
    Rev Bras Anestesiol; 1971; 21(4):812-9. PubMed ID: 5146362
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of benzonal on several adverse effects of cystamine].
    Smirnova SM; Iusipov VS; Zaĭtseva TG
    Farmakol Toksikol; 1975; 38(1):86-8. PubMed ID: 1112402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of diallyl-nor-toxiferine in man].
    Raaflaub J; Frey P
    Arzneimittelforschung; 1972 Jan; 22(1):73-8. PubMed ID: 5067002
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass spectrometric determination of butobarbitone and its metabolites in man.
    Gilbert JN; Powell JW
    Biomed Mass Spectrom; 1974 Apr; 1(2):142-4. PubMed ID: 4433727
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
    Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolism of 5-vinyl-5-(1'-methylbutyl)-barbituric acid (Vinylbital) in human. 2. Course of metabolite elimination of racemic vinylbital in urine].
    Geldmacher-von Mallinck ; Egger B; Fröhlich F
    Arzneimittelforschung; 1971 Jul; 21(7):939-41. PubMed ID: 5109505
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on kinetics of degradation of drugs. XIX. Thermic degradation of aminophenazone (AP), allobarbital (AB), cycloadiphenine hydrochloride (CAD) mixture in cetyl phtalate medium.
    Pawelczyk E; Hermann T; Marciniec B; Pluta I
    Acta Pol Pharm; 1971; 28(6):594-602. PubMed ID: 5163824
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates.
    Büch H; Knabe J; Buzello W; Rummel W
    J Pharmacol Exp Ther; 1970 Dec; 175(3):709-16. PubMed ID: 5496138
    [No Abstract]   [Full Text] [Related]  

  • 19. Species differences in metabolism and excretion of bromhexine in mice, rats, rabbits, dogs and man.
    Kopitar Z; Jauch R; Hankwitz R; Pelzer H
    Eur J Pharmacol; 1973 Jan; 21(1):6-10. PubMed ID: 4709208
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of cyclamates in rats.
    Wallace WC; Lethco EJ; Brouwer EA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):325-30. PubMed ID: 5481702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.